Dr. Yonghua Zhang, MD

Dr. Zhang practices at Edward Hospital in Naperville, Illinois, part of Endeavor Health.

Dr. Zhang's NPI, 1740503960, was assigned on March 2, 2010. Dr. Zhang holds Illinois license 036-124698.

Dr. Zhang's primary practice is Edward Hospital, at 801 South Washington, Naperville, IL 60540 in Du Page County. The practice phone is (630) 527-3000.

Dr. Zhang's primary practice is Edward Hospital in Naperville, Illinois, part of Endeavor Health. Dr. Zhang is also affiliated with Elmhurst Hospital. The medical group on file is Endeavor Health Medical Group. Dmand AI also links Dr. Zhang to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zhang practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Zhang's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Zhang is licensed in Illinois.

CMS data shows 607 Medicare services from Dr. Zhang across 8 procedure codes in 2024, for 420 Medicare patients. Medicare paid $68,166 for them.

CMS counts 420 Medicare patients who saw Dr. Zhang in 2024. The largest group is 65 to 74, with 160 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zhang's median patient age at 63, with 63% women.

In 2024, Dr. Zhang wrote 2,010 Medicare Part D claims for 429 patients. 91% of them were for generic drugs. CMS names the drug for 1,797 of them, across 34 drugs with 11 or more claims each, at $396,180 in total drug cost. In 2023, CMS named 1,593 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Zhang for performance year 2024, reported as part of a group. Dr. Zhang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zhang as offering telehealth.

Dmand AI links 9 papers to Dr. Zhang, published from 2013 to 2020. 2017 was the busiest year, with 3. The most frequent topics are Antibodies, Monoclonal, Immunoglobulin G and Chromatography, High Pressure Liquid. Dr. Zhang has published most often in J Pharm Biomed Anal. Dr. Zhang's most frequent co-authors are Shuo Qian, MD, Kevin Tae Il Whang, MD and Bing Zhang.

CMS Open Payments shows 25 general payments to Dr. Zhang from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 68% of the total. LivaNova USA, Inc. paid the most, $704.